You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: May 3, 2024

Reata Pharms Company Profile


✉ Email this page to a colleague

« Back to Dashboard


What is the competitive landscape for REATA PHARMS, and what generic alternatives to REATA PHARMS drugs are available?

REATA PHARMS has one approved drug.

There are six US patents protecting REATA PHARMS drugs.

There are seventy-three patent family members on REATA PHARMS drugs in thirty-five countries.

Summary for Reata Pharms
International Patents:73
US Patents:6
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Reata Pharms

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Reata Pharms SKYCLARYS omaveloxolone CAPSULE;ORAL 216718-001 Feb 28, 2023 RX Yes Yes 8,124,799 ⤷  Try a Trial Y ⤷  Try a Trial
Reata Pharms SKYCLARYS omaveloxolone CAPSULE;ORAL 216718-001 Feb 28, 2023 RX Yes Yes 8,440,854 ⤷  Try a Trial Y ⤷  Try a Trial
Reata Pharms SKYCLARYS omaveloxolone CAPSULE;ORAL 216718-001 Feb 28, 2023 RX Yes Yes ⤷  Try a Trial ⤷  Try a Trial
Reata Pharms SKYCLARYS omaveloxolone CAPSULE;ORAL 216718-001 Feb 28, 2023 RX Yes Yes 9,701,709 ⤷  Try a Trial Y Y ⤷  Try a Trial
Reata Pharms SKYCLARYS omaveloxolone CAPSULE;ORAL 216718-001 Feb 28, 2023 RX Yes Yes 9,670,147 ⤷  Try a Trial Y ⤷  Try a Trial
Reata Pharms SKYCLARYS omaveloxolone CAPSULE;ORAL 216718-001 Feb 28, 2023 RX Yes Yes 8,993,640 ⤷  Try a Trial Y Y ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.